Raquel Real

Queen Mary University of London — United Kingdom

Medicine · Health Sciences

14h-index659citations63works10.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parkinson's Disease Mechanisms and Treatments(35), Neurological disorders and treatments(10), Cellular transport and secretion(9), Lysosomal Storage Disorders Research(9), Neurological diseases and metabolism(9)

Publications62 total

Identification of common variants influencing risk of the three-repeat tauopathy Pick’s disease: a genome wide association study
2025Open Access
Leveraging blood RNA expression to understand Parkinson’s disease heterogeneity and progression
2025Open Access
Longitudinal Proteomic Profiling Defines Robust Molecular Subtypes Underlying the Heterogeneity of Parkinson’s Disease
2025Open Access
Biomarkers of LRRK2 and lysosomal dysfunction in Progressive Supranuclear Palsy
2025Open Access
Quantitative pathology and APOE genotype reveal dementia risk and progression in Lewy body disease
2025Open Access
Author Reply to Peer Reviews of Trisomy 21 impairs synchronized activity and connectivity in developing human down syndrome cortical excitatory neuron networks
2025
Large-scale genetic characterization of Parkinson’s disease in the African and African admixed populations
Brain·2025· 2 citedOpen Access
Genome-wide association study of REM sleep behavior disorder in Parkinson’s disease
npj Parkinson s Disease·2025Open Access
Data-driven modelling of tau pathology reveals distinct progressive supranuclear palsy subtypes
2025Open Access
Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study
The Lancet Neurology·2025· 19 citedOpen Access
Cryo-EM structures of filaments from the brains of individuals with variants G51D and H50Q in α-synuclein
2025Open Access
Analysis of C9orf72 repeat length in progressive supranuclear palsy, corticobasal syndrome, corticobasal degeneration, and atypical parkinsonism
Journal of Neurology·2025· 2 citedOpen Access
17q21.31 locus regulates Parkinson’s disease relevant pathways through <i>KANSL1</i> activity
2025Open Access
Molecular and cellular signatures differentiate Parkinson’s disease from Parkinson’s disease with dementia
2025· 4 citedOpen Access
Large-scale genetic characterization of Parkinson’s disease in the African and African admixed populations
2025· 2 citedOpen Access
Trisomy 21 Impairs Synchronized Activity in Human Down Syndrome Cortical Excitatory Neuron Networks
2024· 3 citedOpen Access
Diagnostic and prognostic value of alpha-synuclein seed amplification assay in Parkinson’s disease: a longitudinal cohort study
2024Open Access
Parkinson’s families project: a UK-wide study of early onset and familial Parkinson’s disease
npj Parkinson s Disease·2024· 19 citedOpen Access
Genome-wide determinants of mortality and motor progression in Parkinson’s disease
npj Parkinson s Disease·2024· 14 citedOpen Access
MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study
The Lancet Neurology·2024· 22 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Huw R. Morris(39), Alejandro Martínez-Carrasco(18), John Hardy(18), Joshua Shulman(17), Donald G. Grosset(17), Mina Ryten(16), Manuela Tan(16), Lesley Wu(15), Michael Lawton(14), Yoav Ben‐Shlomo(13), Cornelis Blauwendraat(13), Maryam Shoai(12), Nigel Williams(12), Regina H. Reynolds(11), Thomas Foltynie(11), Hirotaka Iwaki(11), Alexis Brice(10), Andrew Singleton(10), Henry Houlden(9), Dan Vitale(9)